Clinical Trials Browser

Phase 2 × NIH × Arsenic Trioxide × Clear all

NCT00003885 2013-11-06

Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma

Phase 2 Unknown

DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Blast Crisis, Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

NCT00085345 2013-07-10

Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Withdrawn

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00112879 2013-07-10

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma

Phase 2 Withdrawn

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00036842 2013-06-24

Arsenic Trioxide in Treating Men With Germ Cell Cancer

Phase 2 Completed

Testicular Germ Cell Tumor, Testicular Neoplasms

NCT00005618 2013-06-21

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia

Phase 2 Completed

Other hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

NCT00005999 2013-06-21

Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms

NCT00006008 2013-06-21

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00009867 2013-06-04

Arsenic Trioxide in Treating Patients With Urothelial Cancer

Phase 2 Completed

Ureteral Neoplasms, Urethral Neoplasms

NCT00061958 2013-01-23

Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction

Phase 2 Terminated

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms